shopping cart Your cart is empty
  • Home
  • Healthcare
  • Technologies For Long Term Care And Home Healthcare Market, Industry Size, Growth, Share And Forecast To 2022

Technologies For Long Term Care And Home Healthcare Market, Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Mar 10, 2016

Key Findings

 

The technologies for long term care and home healthcare market is expected to grow at the CAGR of 18.3% during 2015-2022. 

The most important factor in the growth of global technologies for long term care and home healthcare market is the advancements in technologies in healthcare market. Rising geriatric population and increasing need for economical treatment options has led to the growth of the technology for long term care. In addition to adoption of technology and broadband connectivity by elderly people has made a significant impact in the demand for the services of home care. Rise in incidences of chronic diseases has contributed significantly to the market growth of technologies for long term care and home healthcare. Some of the benefits offered by application of technology in home healthcare are physiological monitoring such as weight, vital signs etc., detection of emergencies on right time, provides safety and security to the health of the users. Continuous research and development activities going on the field leading to the development of better technologies for long term care and home healthcare products. Also there are certain opportunities in the market which can be the major cause for the high growth of the market in the forecasted period such as the upcoming trend towards tele-health and untapped developing regions.

 

Some of the factors acting as the restraint for the market are the lack of knowledge and skills to cope up with technological changes, changes in reimbursement policies, and also lack of financial resources. Low level of awareness about the advantages of technologies for long term care and home healthcare among peopleis one of the major restraints being faced by the industry.

 

Market Segment Insight

 

The global market of technologies for long term care and home healthcare is segmented on the basis of type, product, software, service and regional outlook. On the basis of product, the global technologies market for long term care is segregated into monitoring and testing products, healthcare therapeutic products and home healthcare mobility care products. The testing and monitoring products segment is anticipated to account for the highest market share over the forecasted period. Monitoring & testing products is segregated into blood glucose monitors, fetal monitoring, sleep apnea monitors, cholesterol monitoring devices, pedometers, temperature monitors, blood pressure monitors, heart rate monitors and so on.  Furthermore, the market is segmented by software into clinical management systems, hospice solutions, and agency software. Clinical Management system is anticipated to witness the significant growth in the market. Based on the services it is bifurcated asinfusion therapy services, pregnancy care services, hospice and palliative care services, rehabilitation therapy services, unskilled care services, respiratory therapy services and nursing care services.The infusion therapy services are anticipated to show the significant growth over the forecasted period.Telehealth monitoring devices are anticipated to account for the highest share of the global technology market for long term care.Based on the type, the market has been categorized into home telehealth monitoring devices, home telehealth software and home telehealth services.

 

Regional Insight

 

Based on geography the industry is divided into North America, Europe, Asia pacific, Middle East and Africa, Latin America and ROW. North America has the largest share in the global technologies for long term care and home healthcare market followed by Europe, Asia Pacific and Rest of the World. Asia Pacific is anticipated to witness significant growth during the forecasted period. Rising geriatric population, increasing demand for economical treatment options, rising incidence of chronic diseases and government initiatives to propel home healthcare will significantly drive the growth of thelong term care and home healthcare market.

 

Competitive Insights

 

The key players in this market are Abbott laboratories, General Electric Co., Drager Medical Gmbh, Johnson & Johnson, Philips Healthcare, Omron Healthcare,Covidien, 3M Co., Nonin Medical, Siemens A.G., Mortara Instruments Inc., Roche Diagnostics Ltd. etc.

 

Reasons for Buying the Report

 

  • This report provides a detailed study of current trends in the global technologies for long term care and home healthcarekey growth drivers, and restraints.
  • It provides market forecast for the next 7 years (2015-2022) assessed on the basis of market growth.
  • The report also includes analysis of recent advancements in the global technologies for long term care and home healthcaremarket, analysis of key market players and the key winning strategy adopted and predictive analysis.
  • The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
  • The report tracks and analyse the changing market dynamics.

CHAP1. METHODOLOGY & SCOPE 12
    1.1. RESEARCH METHODOLOGY 12
    1.2. RESEARCH SCOPE & ASSUMPTIONS 12
    1.3. LIST OF DATA SOURCES 12


CHAP2. EXECUTIVE SUMMARY 13
    2.1. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET SUMMARY & KEY BUYING CRITERIA 13
    2.2. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET OUTLOOK 13
    2.3. MARKET SEGMENTATION 13
    2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
    2.5. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET VALUE CHAIN ANALYSIS 13
    2.6. VENDOR LANDSCAPE 13


CHAP3. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET 14
    3.1. MARKET DRIVER ANALYSIS 14
        3.1.1. INCREASING INCIDENCES OF CHRONIC DISEASES 14
        3.1.2. GROWTH IN GERIATRIC POPULATION 14
        3.1.3. RISING NEED FOR ECONOMICAL TREATMENT OPTIONS 14
      3.1.4. ADOPTION OF TECHNOLOGY AND BROADBAND CONNECTIVITY BY ELDERLY PEOPLE 14
        3.1.5. GOVERNMENT INITIATIVES TO PROPEL HOME HEALTHCARE 14
    3.2. MARKET RESTRAINT ANALYSIS 14
        3.2.1. LACK OF KNOWLEDGE AND EXPERIENCE TO COPE UP WITH TECHNOLOGICAL CHANGE 14
        3.2.2. LACK OF FINANCIAL RESOURCES 14
        3.2.3. LIMITED INSURANCE COVERAGE 14
        3.2.4. CHANGES IN REIMBURSEMENT POLICIES 14
    3.3. KEY OPPORTUNITIES 14
        3.3.1. UNTAPPED DEVELOPING REGIONS 14
        3.3.2. SHIFTING TREND TOWARDS TELEHEALTH 14
    3.4. CHALLENGES 14
        3.4.1. LACK OF TRAINED PERSONNEL 14
        3.4.2. HIGH COSTS AND PRIVACY ISSUES 14


CHAP4. INDUSTRY ANALYSIS 15
    4.1. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET– PORTER’S FIVE FORCE MODEL 15
    4.2. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET– PESTEL ANALYSIS 15

 

CHAP5. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET BY PRODUCT 2012-2022 ($ BILLION) 16
    5.1. GLOBAL MONITORING & TESTING PRODUCTS MARKET 2012-2022 ($ BILLION) 17
        5.1.1. GLOBAL BLOOD GLUCOSE MONITORS MARKET 2012-2022($ BILLION) 17
        5.1.2. GLOBAL PEAK FLOW METERS MARKET2012-2022($ BILLION) 17
        5.1.3. GLOBAL FETAL MONITORING MARKET 2012-2022($ BILLION) 17
        5.1.4. GLOBAL SLEEP APNEA MONITORS MARKET 2012-2022($ BILLION) 17
        5.1.5. GLOBAL OVULATION AND PREGNANCY TEST KITS MARKET 2012-2022($ BILLION) 17
        5.1.6. GLOBAL CHOLESTROL MONITORING DEVICES MARKET 2012-2022($ BILLION) 17
        5.1.7. GLOBAL HOME HEMOGLOBIN A1C TEST KITS MARKET 2012-2022($ BILLION) 17
        5.1.8. GLOBAL ECG/EKG MARKET 2012-2022($ BILLION) 17
        5.1.9. GLOBAL TEMPERATURE MONITORS MARKET 2012-2022($ BILLION) 17
        5.1.10. GLOBAL PEDOMETERS MARKET 2012-2022($ BILLION) 17
        5.1.11. GLOBAL BLOOD PRESSURE MONITORS MARKET 2012-2022($ BILLION) 17
        5.1.12. GLOBAL PULSE OXIMETERS MARKET 2012-2022($ BILLION) 17
        5.1.13. GLOBAL HEART RATE MONITORS MARKET 2012-2022($ BILLION) 17
        5.1.14. GLOBAL HIV TEST KITS MARKET 2012-2022($ BILLION) 17
        5.1.15. GLOBAL COAGULATION MONITORS MARKET 2012-2022($ BILLION) 17
        5.1.16. GLOBAL HOLTER AND EVENT MONITORS MARKET 2012-2022($ BILLION) 17
        5.1.17. GLOBAL COLON CANCER MARKET 2012-2022($ BILLION) 17
        5.1.18. GLOBAL DRUG AND ALCOHOL MARKET 2012-2022($ BILLION) 17
        5.1.19. GLOBAL BLOOD EEG DEVICESMARKET 2012-2022($ BILLION) 17
        5.1.20. GLOBAL HEARING AIDS MARKET 2012-2022($ BILLION) 17
    5.2. GLOBAL HEALTHCARE THERAPEUTIC PRODUCTS MARKET 2012-2022 ($ BILLION) 18
        5.2.1. GLOBAL HEALTHCARE THERAPEUTIC MARKET 2012-2022($ BILLION) 18
        5.2.2. GLOBAL SLEEP APNEA THERAPEUTIC MARKET 2012-2022($ BILLION) 18
        5.2.3. GLOBAL IV EQUIPMENT MARKET 2012-2022($ BILLION) 18
        5.2.4. GLOBAL INSULIN DELIVERY DEVICES MARKET 2012-2022($ BILLION) 18
        5.2.5. GLOBAL INHALERS MARKET 2012-2022($ BILLION) 18
        5.2.6. GLOBAL OXYGEN DELIVERY SYSTEMS MARKET 2012-2022($ BILLION) 18
        5.2.7. GLOBAL VENTILATORS MARKET 2012-2022($ BILLION) 18
        5.2.8. GLOBAL WOUND CARE PRODUCTS MARKET 2012-2022($ BILLION) 18
        5.2.9. GLOBAL DIALYSIS MARKET 2012-2022($ BILLION) 18
        5.2.10. GLOBAL OTHER THERAPEUTIC MARKET 2012-2022($ BILLION) 18
    5.3. GLOBAL HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET 2012-2022 ($ BILLION) 18
        5.3.1. GLOBAL CRUCHES MARKET 2012-2022($ BILLION) 18
        5.3.2. GLOBAL WALKERS & ROLLATORS MARKET 2012-2022($ BILLION) 18
        5.3.3. GLOBAL CANES MARKET 2012-2022($ BILLION) 18
        5.3.4. GLOBAL WHEELCHAIRS MARKET 2012-2022($ BILLION) 18
        5.3.5. GLOBAL MOBILITY SCOOTERSMARKET 2012-2022($ BILLION) 18


CHAP6. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET BY TYPE 2012-2022 ($ BILLION) 19
    6.1. GLOBAL HOME TELEHEALTH MONITORING DEVICES MARKET 2012-2022 ($ BILLION) 19
    6.2. GLOBAL HOME TELEHEALTH SOFTWARE MARKET 2012-2022 ($ BILLION) 19
    6.3. HOME TELEHEALTH SERVICES MARKET 2012-2022 ($ BILLION) 19


CHAP7. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET BY SERVICE 2012-2022($BILLION) 20
    7.1. GLOBAL INFUSION THERAPY SERVICES MARKET 2012-2022($BILLION) 20
    7.2. GLOBAL PREGNANCY CARE SERVICES MARKET 2012-2022($BILLION) 20
    7.3. GLOBAL HOSPICE AND PALLIATIVE CARE SERVICES MARKET 2012-2022($BILLION) 20
    7.4. GLOBAL REHABILITATION THERAPY SERVICES MARKET 2012-2022($BILLION) 20
    7.5. GLOBAL UNSKILLED CARE SERVICES MARKET 2012-2022($BILLION) 20
    7.6. GLOBAL RESPIRATORY THERAPY SERVICES MARKET 2012-2022($BILLION) 20
    7.7. GLOBAL NURSING CARE SERVICES MARKET 2012-2022($BILLION) 20


CHAP8. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET BY SOFTWARE 2012-2022($BILLION) 21
    8.1. GLOBAL CLINICAL MANAGEMENT SYSTEMS MARKET 2012-2022($BILLION) 21
    8.2. GLOBAL HOSPICE SOLUTIONS MARKET 2012-2022($BILLION) 21
    8.3. GLOBAL AGENCY SOFTWARE MARKET 2012-2022($BILLION) 21


CHAP9. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET, REGIONAL OUTLOOK 2012-2022 ($ BILLION) 22
    9.1. GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET BY REGION 2012-2022 ($ BILLION) 22
    9.2. NORTH AMERICA 22
        9.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
        9.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 22
        9.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
            9.2.3.1. U.S. 22
                9.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
                9.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
            9.2.3.2. CANADA 22
                9.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
                9.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
    9.3. EUROPE 22
        9.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
        9.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 22
        9.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
                9.3.3.1. GERMANY 22
                9.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 23
                9.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 23
                9.3.3.2. UK 23
                    9.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 23
                    9.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 23
            9.3.3.3. FRANCE 23
                9.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 23
                9.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 23
            9.3.3.4. OTHERS 23
                9.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 23
         9.3.3.4.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 23
    9.4. ASIA PACIFIC 23
        9.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 23
        9.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 23
        9.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 23
            9.4.3.1. CHINA 23
                9.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 23
              9.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 23
            9.4.3.2. INDIA 23
                9.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 24
               9.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 24
            9.4.3.3. JAPAN 24
                9.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 24
               9.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 24
            9.4.3.4. OTHERS 24
                9.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 24
        9.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 24
    9.5. MIDDLE EAST & AFRICA 24
        9.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 24
        9.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 24
    9.6. LATIN AMERICA 24
        9.6.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 24
        9.6.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 24
            9.6.2.1. BRAZIL 24
                9.6.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 25
                9.6.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 25
    9.7. ROW 25
                9.7.1.1.1. ROW MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 25
                9.7.1.1.2. ROW MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 25


CHAP10. COMPETITIVE LANDSCAPE 26
    10.1. ABBOTT LABORATORIES 27
        10.1.1. COMPANY OVERVIEW 27
        10.1.2. FINANCIAL PERFORMANCE 27
        10.1.3. PRODUCT BENCHMARKING 27
        10.1.4. STRATEGIC INITIATIVES 27
    10.2. GENERAL ELECTRIC CO. 27
        10.2.1. COMPANY OVERVIEW 27
        10.2.2. FINANCIAL PERFORMANCE 27
        10.2.3. PRODUCT BENCHMARKING 27
        10.2.4. STRATEGIC INITIATIVES 27
    10.3. DRAGER MEDICAL GMBH 27
        10.3.1. COMPANY OVERVIEW 27
        10.3.2. FINANCIAL PERFORMANCE 27
        10.3.3. PRODUCT BENCHMARKING 27
        10.3.4. STRATEGIC INITIATIVES 27
    10.4. PHILIPS HEALTHCARE 27
        10.4.1. COMPANY OVERVIEW 27
        10.4.2. FINANCIAL PERFORMANCE 27
        10.4.3. PRODUCT BENCHMARKING 27
        10.4.4. STRATEGIC INITIATIVES 27
    10.5. OMRON HEALTHCARE 27
        10.5.1. COMPANY OVERVIEW 27
        10.5.2. FINANCIAL PERFORMANCE 27
        10.5.3. PRODUCT BENCHMARKING 27
        10.5.4. STRATEGIC INITIATIVES 27
    10.6. FRESENIUS MEDICAL CARE AG & CO. KGAA 27
        10.6.1. COMPANY OVERVIEW 27
        10.6.2. FINANCIAL PERFORMANCE 28
        10.6.3. PRODUCT BENCHMARKING 28
        10.6.4. STRATEGIC INITIATIVES 28
    10.7. COVIDIEN 28
        10.7.1. COMPANY OVERVIEW 28
        10.7.2. FINANCIAL PERFORMANCE 28
        10.7.3. PRODUCT BENCHMARKING 28
        10.7.4. STRATEGIC INITIATIVES 28
    10.8. 3M CO. 28
        10.8.1. COMPANY OVERVIEW 28
        10.8.2. FINANCIAL PERFORMANCE 28
        10.8.3. PRODUCT BENCHMARKING 28
        10.8.4. STRATEGIC INITIATIVES 28
    10.9. NONIN MEDICAL (U.S) 28
        10.9.1. COMPANY OVERVIEW 28
        10.9.2. FINANCIAL PERFORMANCE 28
        10.9.3. PRODUCT BENCHMARKING 28
        10.9.4. STRATEGIC INITIATIVES 28
    10.10. AUTONOMIC TECHNOLOGIES 28
        10.10.1. COMPANY OVERVIEW 28
        10.10.2. FINANCIAL PERFORMANCE 28
        10.10.3. PRODUCT BENCHMARKING 28
        10.10.4. STRATEGIC INITIATIVES 28
    10.11. SIEMENS AG 28
        10.11.1. COMPANY OVERVIEW 28
        10.11.2. FINANCIAL PERFORMANCE 28
        10.11.3. PRODUCT BENCHMARKING 28
        10.11.4. STRATEGIC INITIATIVES 28
    10.12. KINNSER SOFTWARE, INC. 29
        10.12.1. COMPANY OVERVIEW 29
        10.12.2. FINANCIAL PERFORMANCE 29
        10.12.3. PRODUCT BENCHMARKING 29
        10.12.4. STRATEGIC INITIATIVES 29
    10.13. JOHNSON & JOHNSON INC. (U.S) 29
        10.13.1. COMPANY OVERVIEW 29
        10.13.2. FINANCIAL PERFORMANCE 29
        10.13.3. PRODUCT BENCHMARKING 29
        10.13.4. STRATEGIC INITIATIVES 29
    10.14. MEDTRONIC INC. 29
        10.14.1. COMPANY OVERVIEW 29
        10.14.2. FINANCIAL PERFORMANCE 29
        10.14.3. PRODUCT BENCHMARKING 29
        10.14.4. STRATEGIC INITIATIVES 29
    10.15. NIHON KOHDEN 29
        10.15.1. COMPANY OVERVIEW 29
        10.15.2. FINANCIAL PERFORMANCE 29
        10.15.3. PRODUCT BENCHMARKING 29
        10.15.4. STRATEGIC INITIATIVES 29
    10.16. ROCHE DIAGNOSTICS LIMITED 29
        10.16.1. COMPANY OVERVIEW 29
        10.16.2. FINANCIAL PERFORMANCE 29
        10.16.3. PRODUCT BENCHMARKING 29
        10.16.4. STRATEGIC INITIATIVES 29
    10.17. MORTARA INSTRUMENTS INC. 29
        10.17.1. COMPANY OVERVIEW 29
        10.17.2. FINANCIAL PERFORMANCE 30
        10.17.3. PRODUCT BENCHMARKING 30
        10.17.4. STRATEGIC INITIATIVES 30
    10.18. STRYKER 30
        10.18.1. COMPANY OVERVIEW 30
        10.18.2. FINANCIAL PERFORMANCE 30
        10.18.3. PRODUCT BENCHMARKING 30
        10.18.4. STRATEGIC INITIATIVES 30
    10.19. BAUSCH & LOMB 30
        10.19.1. COMPANY OVERVIEW 30
        10.19.2. FINANCIAL PERFORMANCE 30
        10.19.3. PRODUCT BENCHMARKING 30
        10.19.4. STRATEGIC INITIATIVES 30
    10.20. ITC 30
        10.20.1. COMPANY OVERVIEW 30
        10.20.2. FINANCIAL PERFORMANCE 30
        10.20.3. PRODUCT BENCHMARKING 30
        10.20.4. STRATEGIC INITIATIVES 30

TABLE 1 GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET BY PRODUCT 2012-2022 ($ BILLION) 32
TABLE 2 GLOBAL MONITORING & TESTING PRODUCTS MARKET 2012-2022 ($ BILLION) 32
TABLE 3 GLOBAL BLOOD GLUCOSE MONITORS MARKET 2012-2022($ BILLION) 32
TABLE 4 GLOBAL PEAK FLOW METERS MARKET2012-2022($ BILLION) 32
TABLE 5 GLOBAL FETAL MONITORING MARKET 2012-2022($ BILLION) 32
TABLE 6 GLOBAL SLEEP APNEA MONITORS MARKET 2012-2022($ BILLION) 32
TABLE 7 GLOBAL OVULATION AND PREGNANCY TEST KITS MARKET 2012-2022($ BILLION) 32
TABLE 8 GLOBAL CHOLESTROL MONITORING DEVICES MARKET 2012-2022($ BILLION) 32
TABLE 9 GLOBAL HOME HEMOGLOBIN A1C TEST KITS MARKET 2012-2022($ BILLION) 32
TABLE 10 GLOBAL ECG/EKG MARKET 2012-2022($ BILLION) 32
TABLE 11 GLOBAL TEMPERATURE MONITORS MARKET 2012-2022($ BILLION) 32
TABLE 12 GLOBAL PEDOMETERS MARKET 2012-2022($ BILLION) 32
TABLE 13 GLOBAL BLOOD PRESSURE MONITORS MARKET 2012-2022($ BILLION) 32
TABLE 14 GLOBAL PULSE OXIMETERS MARKET 2012-2022($ BILLION) 32
TABLE 15 GLOBAL HEART RATE MONITORS MARKET 2012-2022($ BILLION) 32
TABLE 16 GLOBAL HIV TEST KITS MARKET 2012-2022($ BILLION) 32
TABLE 17 GLOBAL COAGULATION MONITORS MARKET 2012-2022($ BILLION) 32
TABLE 18 GLOBAL HOLTER AND EVENT MONITORS MARKET 2012-2022($ BILLION) 32
TABLE 19 GLOBAL COLON CANCER MARKET 2012-2022($ BILLION) 33
TABLE 20 GLOBAL DRUG AND ALCOHOL MARKET 2012-2022($ BILLION) 33
TABLE 21 GLOBAL BLOOD EEG DEVICESMARKET 2012-2022($ BILLION) 33
TABLE 22 GLOBAL HEARING AIDS MARKET 2012-2022($ BILLION) 33
TABLE 23 GLOBAL HEALTHCARE THERAPEUTIC PRODUCTS MARKET 2012-2022 ($ BILLION) 33
TABLE 24 GLOBAL HEALTHCARE THERAPEUTIC MARKET 2012-2022($ BILLION) 33
TABLE 25 GLOBAL SLEEP APNEA THERAPEUTIC MARKET 2012-2022($ BILLION) 33
TABLE 26 GLOBAL IV EQUIPMENT MARKET 2012-2022($ BILLION) 33
TABLE 27 GLOBAL INSULIN DELIVERY DEVICES MARKET 2012-2022($ BILLION) 33
TABLE 28 GLOBAL INHALERS MARKET 2012-2022($ BILLION) 33
TABLE 29 GLOBAL OXYGEN DELIVERY SYSTEMS MARKET 2012-2022($ BILLION) 33
TABLE 30 GLOBAL VENTILATORS MARKET 2012-2022($ BILLION) 33
TABLE 31 GLOBAL WOUND CARE PRODUCTS MARKET 2012-2022($ BILLION) 33
TABLE 32 GLOBAL DIALYSIS MARKET 2012-2022($ BILLION) 33
TABLE 33 GLOBAL OTHER THERAPEUTIC MARKET 2012-2022($ BILLION) 33
TABLE 34 GLOBAL HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET 2012-2022 ($ BILLION) 33
TABLE 35 GLOBAL CRUCHES MARKET 2012-2022($ BILLION) 33
TABLE 36 GLOBAL WALKERS & ROLLATORS MARKET 2012-2022($ BILLION) 33
TABLE 37 GLOBAL CANES MARKET 2012-2022($ BILLION) 33
TABLE 38 GLOBAL WHEELCHAIRS MARKET 2012-2022($ BILLION) 33
TABLE 39 GLOBAL MOBILITY SCOOTERSMARKET 2012-2022($ BILLION) 33
TABLE 40 GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET BY TYPE 2012-2022 ($ BILLION) 34
TABLE 41 GLOBAL HOME TELEHEALTH MONITORING DEVICES MARKET 2012-2022 ($ BILLION) 34
TABLE 42 GLOBAL HOME TELEHEALTH SOFTWARE MARKET 2012-2022 ($ BILLION) 34
TABLE 43 HOME TELEHEALTH SERVICES MARKET 2012-2022 ($ BILLION) 34
TABLE 44 GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET BY SERVICE 2012-2022($BILLION) 34
TABLE 45 GLOBAL INFUSION THERAPY SERVICES MARKET 2012-2022($BILLION) 34
TABLE 46 GLOBAL PREGNANCY CARE SERVICES MARKET 2012-2022($BILLION) 34
TABLE 47 GLOBAL HOSPICE AND PALLIATIVE CARE SERVICES MARKET 2012-2022($BILLION) 34
TABLE 48 GLOBAL REHABILITATION THERAPY SERVICES MARKET 2012-2022($BILLION) 34
TABLE 49 GLOBAL UNSKILLED CARE SERVICES MARKET 2012-2022($BILLION) 34
TABLE 50 GLOBAL RESPIRATORY THERAPY SERVICES MARKET 2012-2022($BILLION) 34
TABLE 51 GLOBAL NURSING CARE SERVICES MARKET 2012-2022($BILLION) 34
TABLE 52 GLOBAL TECHNOLOGIES FOR LONG-TERM CARE AND HOME HEALTHCARE MARKET BY SOFTWARE 2012-2022($BILLION) 34
TABLE 53 GLOBAL CLINICAL MANAGEMENT SYSTEMS MARKET 2012-2022($BILLION) 34
TABLE 54 GLOBAL HOSPICE SOLUTIONS MARKET 2012-2022($BILLION) 34
TABLE 55 GLOBAL AGENCY SOFTWARE MARKET 2012-2022($BILLION) 34

FIGURE 1 MARKET SHARE BY REGIONS 34
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 13 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 35
FIGURE 14 BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022($ BILLION) 35
FIGURE 15 ROW MARKET ESTIMATES AND FORECAST 2012-2022($ BILLION) 35

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)